Lenvima® (lenvatinib)
for Renal Cell Carcinoma

Lenvima (lenvatinib) is a kinase inhibitor used to treat various cancers by blocking specific proteins that promote cancer cell growth and spread. It is prescribed for thyroid cancer when radioactive iodine is ineffective, advanced kidney cancer (alone or with everolimus or pembrolizumab), endometrial cancer with pembrolizumab, and liver cancer that cannot be surgically removed.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Renal Cell Carcinoma - RCC